Clarithromycin and risk of Clostridium difficile-associated diarrhoea

Comment

M H Wilcox. J Antimicrob Chemother. 2001 Mar.

. 2001 Mar;47(3):358-9.

doi: 10.1093/jac/47.3.358.

No abstract available

Comment in

What is an appropriate control group to identify risk factors for Clostridium difficile-associated diarrhoea?
Guyot A, Barrett SP. Guyot A, et al. J Antimicrob Chemother. 2001 Nov;48(5):747-8. doi: 10.1093/jac/48.5.747. J Antimicrob Chemother. 2001. PMID: 11679574 No abstract available.

Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea.
MacGowan AP, Feeney R, Brown I, McCulloch SY, Reeves DS, Lovering AM. MacGowan AP, et al. J Antimicrob Chemother. 1997 Apr;39(4):537-41. doi: 10.1093/jac/39.4.537. J Antimicrob Chemother. 1997. PMID: 9145829
Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy.
McNulty C, Logan M, Donald IP, Ennis D, Taylor D, Baldwin RN, Bannerjee M, Cartwright KA. McNulty C, et al. J Antimicrob Chemother. 1997 Nov;40(5):707-11. doi: 10.1093/jac/40.5.707. J Antimicrob Chemother. 1997. PMID: 9421320 Clinical Trial.
Clarithromycin appears to be linked with Clostridium difficile-associated diarrhoea in the elderly.
Guyot A, Rawlins MD, Barrett SP. Guyot A, et al. J Antimicrob Chemother. 2000 Oct;46(4):642-3. doi: 10.1093/jac/46.4.642. J Antimicrob Chemother. 2000. PMID: 11020269 No abstract available.